Cargando…

Limosilactobacillus reuteri DSM 17938-Containing Infant Formulas and the Associations with Gastrointestinal Tolerance: A Cross-Sectional Observational Study

Limosilactobacillus (L.; previously Lactobacillus) reuteri has been shown to influence gastrointestinal (GI) tolerance. This study was a secondary analysis of GI tolerance data from a multi-country, cross-sectional, observational study in healthy infants using the validated Infant Gastrointestinal S...

Descripción completa

Detalles Bibliográficos
Autores principales: Lavalle, Luca, Sauvageot, Nicolas, Cercamondi, Colin Ivano, Jankovic, Ivana, Egli, Delphine, Vandenplas, Yvan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919438/
https://www.ncbi.nlm.nih.gov/pubmed/36771237
http://dx.doi.org/10.3390/nu15030530
_version_ 1784886825110732800
author Lavalle, Luca
Sauvageot, Nicolas
Cercamondi, Colin Ivano
Jankovic, Ivana
Egli, Delphine
Vandenplas, Yvan
author_facet Lavalle, Luca
Sauvageot, Nicolas
Cercamondi, Colin Ivano
Jankovic, Ivana
Egli, Delphine
Vandenplas, Yvan
collection PubMed
description Limosilactobacillus (L.; previously Lactobacillus) reuteri has been shown to influence gastrointestinal (GI) tolerance. This study was a secondary analysis of GI tolerance data from a multi-country, cross-sectional, observational study in healthy infants using the validated Infant Gastrointestinal Symptom Questionnaire (IGSQ) and a gut comfort questionnaire. Breastfed infants (BFI; n = 760) were compared to formula-fed infants receiving either L. reuteri-containing formula (FFI + LR; n = 470) or standard formula without any probiotic or prebiotic (FFI-Std; n = 501). The IGSQ composite scores (adjusted mean ± SE) in FFI + LR (22.17 ± 0.39) was significantly lower than in FFI-Std (23.41 ± 0.37) and similar to BFI (22.34 ± 0.30;), indicating better GI tolerance in FFI + LR than in FFI-Std. Compared with FFI-Std, FFI + LR had lower reports of difficulty in passing stools (11% vs. 22%; adjusted-odds ratio (OR) (95%CI) = 0.46 (0.31–0.68)), fewer hard stools (mean difference = −0.12 (−0.21, −0.02)) and less physician-confirmed colic (OR = 0.61 (0.45–0.82)), and similar to BFI. Parent-reported crying time (mean difference = −0.15 (−0.28, −0.01)), frequency of spitting-up/vomiting (mean difference = −0.18 (−0.34, −0.03)), volume of spit-up (mean difference = −0.20 (−0.32, −0.08)) and fussiness due to spitting-up/vomiting (mean difference = −0.17 (−0.29, −0.05)) were lower in FFI + LR versus FFI-Std and similar to BFI. In this study, L. reuteri-containing formula was associated with improved digestive tolerance and behavioral patterns.
format Online
Article
Text
id pubmed-9919438
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99194382023-02-12 Limosilactobacillus reuteri DSM 17938-Containing Infant Formulas and the Associations with Gastrointestinal Tolerance: A Cross-Sectional Observational Study Lavalle, Luca Sauvageot, Nicolas Cercamondi, Colin Ivano Jankovic, Ivana Egli, Delphine Vandenplas, Yvan Nutrients Article Limosilactobacillus (L.; previously Lactobacillus) reuteri has been shown to influence gastrointestinal (GI) tolerance. This study was a secondary analysis of GI tolerance data from a multi-country, cross-sectional, observational study in healthy infants using the validated Infant Gastrointestinal Symptom Questionnaire (IGSQ) and a gut comfort questionnaire. Breastfed infants (BFI; n = 760) were compared to formula-fed infants receiving either L. reuteri-containing formula (FFI + LR; n = 470) or standard formula without any probiotic or prebiotic (FFI-Std; n = 501). The IGSQ composite scores (adjusted mean ± SE) in FFI + LR (22.17 ± 0.39) was significantly lower than in FFI-Std (23.41 ± 0.37) and similar to BFI (22.34 ± 0.30;), indicating better GI tolerance in FFI + LR than in FFI-Std. Compared with FFI-Std, FFI + LR had lower reports of difficulty in passing stools (11% vs. 22%; adjusted-odds ratio (OR) (95%CI) = 0.46 (0.31–0.68)), fewer hard stools (mean difference = −0.12 (−0.21, −0.02)) and less physician-confirmed colic (OR = 0.61 (0.45–0.82)), and similar to BFI. Parent-reported crying time (mean difference = −0.15 (−0.28, −0.01)), frequency of spitting-up/vomiting (mean difference = −0.18 (−0.34, −0.03)), volume of spit-up (mean difference = −0.20 (−0.32, −0.08)) and fussiness due to spitting-up/vomiting (mean difference = −0.17 (−0.29, −0.05)) were lower in FFI + LR versus FFI-Std and similar to BFI. In this study, L. reuteri-containing formula was associated with improved digestive tolerance and behavioral patterns. MDPI 2023-01-19 /pmc/articles/PMC9919438/ /pubmed/36771237 http://dx.doi.org/10.3390/nu15030530 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lavalle, Luca
Sauvageot, Nicolas
Cercamondi, Colin Ivano
Jankovic, Ivana
Egli, Delphine
Vandenplas, Yvan
Limosilactobacillus reuteri DSM 17938-Containing Infant Formulas and the Associations with Gastrointestinal Tolerance: A Cross-Sectional Observational Study
title Limosilactobacillus reuteri DSM 17938-Containing Infant Formulas and the Associations with Gastrointestinal Tolerance: A Cross-Sectional Observational Study
title_full Limosilactobacillus reuteri DSM 17938-Containing Infant Formulas and the Associations with Gastrointestinal Tolerance: A Cross-Sectional Observational Study
title_fullStr Limosilactobacillus reuteri DSM 17938-Containing Infant Formulas and the Associations with Gastrointestinal Tolerance: A Cross-Sectional Observational Study
title_full_unstemmed Limosilactobacillus reuteri DSM 17938-Containing Infant Formulas and the Associations with Gastrointestinal Tolerance: A Cross-Sectional Observational Study
title_short Limosilactobacillus reuteri DSM 17938-Containing Infant Formulas and the Associations with Gastrointestinal Tolerance: A Cross-Sectional Observational Study
title_sort limosilactobacillus reuteri dsm 17938-containing infant formulas and the associations with gastrointestinal tolerance: a cross-sectional observational study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919438/
https://www.ncbi.nlm.nih.gov/pubmed/36771237
http://dx.doi.org/10.3390/nu15030530
work_keys_str_mv AT limosilactobacillusreuteridsm17938containinginfantformulasandtheassociationswithgastrointestinaltoleranceacrosssectionalobservationalstudy
AT lavalleluca limosilactobacillusreuteridsm17938containinginfantformulasandtheassociationswithgastrointestinaltoleranceacrosssectionalobservationalstudy
AT sauvageotnicolas limosilactobacillusreuteridsm17938containinginfantformulasandtheassociationswithgastrointestinaltoleranceacrosssectionalobservationalstudy
AT cercamondicolinivano limosilactobacillusreuteridsm17938containinginfantformulasandtheassociationswithgastrointestinaltoleranceacrosssectionalobservationalstudy
AT jankovicivana limosilactobacillusreuteridsm17938containinginfantformulasandtheassociationswithgastrointestinaltoleranceacrosssectionalobservationalstudy
AT eglidelphine limosilactobacillusreuteridsm17938containinginfantformulasandtheassociationswithgastrointestinaltoleranceacrosssectionalobservationalstudy
AT vandenplasyvan limosilactobacillusreuteridsm17938containinginfantformulasandtheassociationswithgastrointestinaltoleranceacrosssectionalobservationalstudy